Supplements and Featured Publications
Abriendo Puertas a los Profesionales con el Multimodal Maestro2
The Only Branded Steroid Indicated for Inflammation Associated with a Range of Ocular Surface Conditions
A Reliable Treatment for Blepharitis/Meibomian Gland Dysfunction, with Increased Ocular Bioavailability
Glaucoma 360: Highlights from 2021
Glaucoma 360: Highlights from 2020
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
Topcon Healthcare seeks to advance company through acquisition and new investment
3
What if? Ophthalmology without OCT – Part 3
4
Throwback Series: From epidemic to innovation in corneal surgery
5
.png "Optometry Times"){kind=logo}
